BLRX
BioLineRx Ltd
NASDAQ: BLRX · HEALTHCARE · BIOTECHNOLOGY
$2.79
-9.12% today
Updated 2026-04-30
Market cap
$10.21M
P/E ratio
0.00
P/S ratio
8.66x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$2 – $8
Volume
0.0M
BioLineRx Ltd (BLRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |